These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 30520504)

  • 1. Knowledge and practice in the management of asymptomatic hyperuricemia among primary health care physicians in Jeddah, Western Region of Saudi Arabia.
    Alqarni NA; Hassan AH
    Saudi Med J; 2018 Dec; 39(12):1218-1225. PubMed ID: 30520504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of poor response to urate-lowering therapy in patients with gout and hyperuricemia: a post-hoc analysis of a multicenter randomized trial.
    Mu Z; Wang W; Wang J; Lv W; Chen Y; Wang F; Yu X; Wang Y; Cheng B; Wang Z
    Clin Rheumatol; 2019 Dec; 38(12):3511-3519. PubMed ID: 31410659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge and Practice of Primary Health Care Providers in the Management of Asymptomatic Hyperuricemia and Gout in the Qassim Region of Saudi Arabia.
    Alraqibah EA; Alharbi FM; Alharbi NS; Aldekhail MI; Alahmadi KM; Alresheedi MA; AlKhattaf MI
    Cureus; 2022 Nov; 14(11):e30976. PubMed ID: 36337303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness, practices, and barriers regarding smoking cessation treatment among physicians in Saudi Arabia.
    Jradi H
    J Addict Dis; 2017; 36(1):53-59. PubMed ID: 26566876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire.
    Harrold LR; Mazor KM; Negron A; Ogarek J; Firneno C; Yood RA
    Rheumatology (Oxford); 2013 Sep; 52(9):1623-9. PubMed ID: 23620554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing Urate Lowering Therapies prescription for asymptomatic hyperuricemia by general practitioners: a qualitative study.
    Tourzel E; Munck S; Fournier JP; Maisonneuve H
    Int J Clin Pract; 2019 Sep; 73(9):1-11. PubMed ID: 31250954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database.
    Honda M; Horiuchi H; Torii T; Nakajima A; Iijima T; Murano H; Yamanaka H; Ito S
    BMC Pediatr; 2021 Dec; 21(1):581. PubMed ID: 34922491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge, attitudes, and practices regarding diabetic retinopathy among primary health care physicians in Al-Hasa, Saudi Arabia.
    Alhejji AE; Alsultan MA; Alshareet MA; Alkhamis FA; Aljaafary MA; Alshaqaqiq AI; Nabouli MR; Ibrahim Ali S
    J Prev Med Hyg; 2020 Mar; 61(1):E85-E91. PubMed ID: 32490273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing trend of asymptomatic hyperuricemia under treatment with urate-lowering drugs in Japan.
    Hakoda M; Kasagi F
    Mod Rheumatol; 2019 Sep; 29(5):880-884. PubMed ID: 30175646
    [No Abstract]   [Full Text] [Related]  

  • 10. Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China.
    Li QH; Dai L; Li ZX; Liu HJ; Zou CJ; Ou-Yang X; Lu M; Li T; Li YH; Mo YQ; Schumacher HR
    Clin Rheumatol; 2013 Nov; 32(11):1633-40. PubMed ID: 23857664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Primary Healthcare Providers' Knowledge and Practices in Addressing Asymptomatic Hyperuricemia and Gout in the Asir Region of Saudi Arabia.
    Tawhari I; AlQahtani OA; Alqahtani MS; Alshehri RM; Alsairy MA; Alqahtani SM; Aljaber AM; Alshahrani MM; Alqahtani AM; Alahmary MA; Alsuairi NM
    Cureus; 2024 Jan; 16(1):e51745. PubMed ID: 38187028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
    Fujimori S
    Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world treatment of gout and asymptomatic hyperuricemia: A cross-sectional study of Japanese health insurance claims data.
    Koto R; Nakajima A; Horiuchi H; Yamanaka H
    Mod Rheumatol; 2021 Jan; 31(1):261-269. PubMed ID: 32552370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD).
    Mikuls TR; Farrar JT; Bilker WB; Fernandes S; Saag KG
    Rheumatology (Oxford); 2005 Aug; 44(8):1038-42. PubMed ID: 15870145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of the assessment and management of gout in general practitioners and medical officers within the Illawarra Network, Australia.
    Terrill M; Riordan J
    Int J Rheum Dis; 2017 Aug; 20(8):990-995. PubMed ID: 27153502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hyperuricemia, gout and other crystalline arthritidies.
    Lioté F
    Reumatismo; 2012 Jan; 63(4):276-83. PubMed ID: 22303534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice.
    Cottrell E; Crabtree V; Edwards JJ; Roddy E
    BMC Fam Pract; 2013 Nov; 14():170. PubMed ID: 24225170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN).
    Dalbeth N; Bardin T; Doherty M; Lioté F; Richette P; Saag KG; So AK; Stamp LK; Choi HK; Terkeltaub R
    Nat Rev Rheumatol; 2017 Sep; 13(9):561-568. PubMed ID: 28794514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of gout in the real world: current practice versus guideline recommendations.
    Doghramji PP; Fermer S; Wood R; Morlock R; Baumgartner S
    Postgrad Med; 2016 Jan; 128(1):106-14. PubMed ID: 26592538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COPD care in Saudi Arabia: physicians' awareness and knowledge of guidelines and barriers to implementation.
    Alsubaiei ME; Frith PA; Cafarella PA; Quinn S; Al Moamary MS; McEvoy RD; Effing TW
    Int J Tuberc Lung Dis; 2017 May; 21(5):592-595. PubMed ID: 28399976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.